Chronic Q fever in abdominal aortic disease

Completed

• Conditions: aneurysm; chronic Q fever; vascular prosthesis; 10004018; 10002363

• Registration Number: NL-OMON46120
• Lead Sponsor: Jeroen Bosch Ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2019-07-01
• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 46

Inclusion Criteria

Patients with an aortic aneurysm (>30 mm), iliac aneurysm (>12mm) or central vascular reconstruction (such as EVAR op open reconstruction)
aged 18 years or older

Exclusion Criteria

No informed consent obtained
Legal incapability

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary outcome: incidence of chronic Q fever and seronegativity </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secundary outcome: evaluate possible risk factors for developing chronic Q<br /><br>fever by comparing seronegative patients and remaining seropositive patients<br /><br>with chronic Q fever patients.</p><br>